Menu
23 Apr 2018 | 10:13 AM
 

Bharat Immunological & Biologicals Corporation Ltd. Share Price Live (BSE)
0

BSE Code: 524663 | NSE Symbol:
24.00
0.30
(1.27 %)
23 Apr 2018 | 09:59 AM
Change company
  • Open (Rs)
    24.30
  • Prev. close (Rs.)
    23.70
  • High (Rs.)
    24.30
  • Low (Rs.)
    23.80
  • 52W H (Rs.)
    38.71
  • 52W L (Rs.)
    18.25
  • Volume
    117
  • MCap (Rs in Cr.)
    103.64
F&O Futures F&O Options
Expiry Date
  • Open (Rs)
  • High (Rs)
  • Low (Rs)
  • Prev. close(Rs)
  • Contracts Tra.
  • Turnover (Cr.)
  • Open Interest
  • Open Int. chg
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

News

Bharat Immunological & Biologicals Q3 net profit down 65.03%
16 Jan 2018 - 11:17:00-The company reported standalone net profit of Rs 0...
Bharat Immunolog posts Q2 net loss of Rs 2.39 cr
27 Oct 2017 - 12:37:00-The company reported standalone net loss during the quarter stood at Rs 2...
Bharat Immunolog posts Q1 net loss of Rs 1.98 cr
25 Jul 2017 - 14:00:00-Net sales of the company declined substantially by 87.95 per cent at Rs 3...
Bharat Immunologicals net profit surges by 142 per cent
13 May 2016 - 14:35:00-Bharat Immunologicals & Biologicals Corporation Ltd net profit surge by 142 per cent

Net pro...

Announcements

13-Apr-2018
Bharat Immunolog - Intimation Of Date Of Board Meeting On 24.04.2018 Under Regulation 29 Of SEBI`S LODR
10-Apr-2018
Bharat Immunolog - Shareholding for the Period Ended March 31 2018
22-Jan-2018
Bharat Immunolog - Un Audited Quarterly Financial Results For The Quarter Ended December 2017 Of 201718
17-Jan-2018
Bharat Immunolog - Shareholding for the Period Ended December 31 2017
03-Nov-2017
Bharat Immunolog - Submission Of Certificate From Practicising Company Secretary Under Regulation 40 Of SEBI (LODR) Regulatio

Religare Research

Religare Weekly Equity
20 Apr 2018 | 07:00 PM
In continuation to prevailing up trend, Nifty rallied for the fourth consecutive week in a row and g...
Master Pick Update 20th April, 2018
20 Apr 2018 | 06:00 PM
Nifty has strong hurdle around 10600-10650 zone and it also showing early sign of exhaustion for las...
Indian Rupee FY 18-19 Update
20 Apr 2018 | 05:44 PM
The Indian rupee has fallen to over 13-month low against the dollar, breaching the crucial 66 (spot)...
Daily Techno Funda
20 Apr 2018 | 10:34 AM
DTF

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors59.25%
Mutual Funds/UTI0.00%
FI/Banks0.01%
Insurance0.01%
FII0.00%
Government0.00%
Others5.49%

Peer Group

Company Intraday Graph
 DIL Ltd.
3,000.00(-0.28)
 3299
 Hester Biosciences Ltd.
1,602.45(-2.10)
 3572
 Kovai Medical Center and Hospital Ltd.
1,318.00(0.23)
 11816
 TTK Healthcare Ltd.
1,060.10(-0.60)
 3392

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Bharat Immunological & Biologicals Corporation Ltd.3.40-3.251.65
NIFTY(S&P CNX)461.55-380.30401.05
BSE SENSEX1,399.64-1,401.611,889.68
BSE 500703.29-647.08637.85

Corporate Details

Key Personal
Chandra Prakash Goyal
Managing Director
G Padmanaban
Chairman
M K Bhan
Chairman
Key Address
Registered Office
BIBCOL OPV Plant Village Chola,Bulandshahar Dist,Uttar Pradesh

Tel:05732-238758 238763-68 238210, Fax:05732-238757

complianceofficer_bibcol@yahoo.in
http://www.bibcol.com
Registrar Office
Beetal Financial & Computer Services (P) Ltd
Add. :Beetal House 3rd Floor 99 Madangir Behind Local Shopping Centre Near Dada Harsukhdas Mandir
QUICK LINKS
RELIGARE ONLINE
IMPORTANT LINKS
EXPLORE RELIGARE
Stocks Directory
Mutual Funds Directory
Investor Complaints
Attention Investors

Prevent unauthorized transactions in your account - Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day - Issued in the interest of Investors.

Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Depository (NSDL/CDSL) on the same day issued in the interest of investors.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investors account.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Trading and Demat Accounts opened under Insta Plan will not be eligible for dealing through branches.

Kindly update your aadhar with us here. UPDATE AADHAAR
Follow us on
Unified Portal Version No.1.0.0.1
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights reserved.
Religare Broking Limited, Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
Broking Business of Religare Securities Ltd ( RSL) has been transferred and vested in Religare Broking Limited ( RBL) , pursuant to NCLT order.
Religare is a registered trademark of RHC Holding Private Limited used under license by Religare Enterprises Limited and its subsidiaries.
  • Member (Religare Securities Limited) :
  • NSE: SEBI Regn. No: INB 230653732, INF 230653732 & INE 230653732 TM Co: 06537
  • Clearing Member (F&O) No. M50235 BSE:SEBI Regn. No: INB 010653732 & INF 010653732 |
  • Clearing No: 3004 |
  • MSEI SEBI Regn. No: INB260653739, INF260653739 & INE260653732 TM Co: 1051 Clearing Member (F&O) No. 51 |
  • NSDL: DP ID: IN 301774 |
  • SEBI Regn. No: IN-DP-NSDL-150-2000 |
  • CDSL DP ID: 30200 SEBI Regn. No: IN-DP-CDSL-202-2003 |
  • Research Analyst SEBI Regi. No.: INH100001831 |
    Religare Commodities Limited- Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
  • Member :
  • NCDEX: Member ID - 00109 |
  • MCX: Member ID - 10575 |
  • SEBI Registration Number- INZ000022334|
  • NSEL Member ID- 10180 |
  • NCDEX Emarket Member ID - 10042 |
The Site is best viewed with screen resolution 1024x768. The compatible browsers are Mozilla Firefox, Google Chrome and IE 8 (or above)